Fidaxomicin (Fificid) emerged favorable to vancomycin for the treatment of both initial and recurrent Clostridioides difficile infections in a Medicare population, according to a new retrospective study. Although fidaxomicin was about 14% more effective than vancomycin in treating the initial infection, a larger difference of 30% was found among people with recurrent C difficile infections. Lead investigator […]
A small study conducted in Germany takes a step toward quantifying the COVID risk of gyms and fitness clubs. Scientists have known since early in the pandemic that COVID is usually spread in the air by aerosol particles expelled by infected people, and the harder people breathe — as when […]
Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. SARS-CoV-2 is a strange virus, and not only because it is so novel. The variability in clinical presentation and outcome is still perplexing; the emergence of […]
After a dip in US reports of sexually transmitted diseases (STDs) early in the COVID-19 pandemic, cases have resurged, according to the CDC’s 2020 STD Surveillance Report. Centers for Disease Control and Prevention The report noted that the decline in cases was likely due to pandemic-related disruptions in care and several other factors: […]
De momento las vacunas de AstraZeneca-Oxford, Pfizer-BioNTech y Moderna son las únicas que han sido identificadas con esta molestia. Los efectos secundarios con la orina más frecuentes fueron el almacenamiento. El STUI constituye la enfermedad urológica más frecuente en varones de edad avanzada. Desde hace más de año y medio […]
Results of the COVI-PRONE trial do not support prone positioning for awake non-intubated COVID-19 patients with acute respiratory distress. However, the effect size for the primary outcome (intubation) was “imprecise and does not exclude a clinically important benefit,” the study team says in JAMA. The COVI-PRONE trial enrolled 400 adult […]
In a prospective, longitudinal study, N-antibodies peaked 90–100 days after infection and persisted for at least 500 days in most patients. The duration of antibody response after SARS-CoV-2 infection is not clearly established, although prior studies have estimated that antibodies produced after natural infection last from 3 to 6 months. […]
A chain of events possibly triggered by unrecognized infection with the SARS-CoV-2 coronavirus could be causing the mysterious cases of severe hepatitis reported in hundreds of young children around the world, researchers suggest. Children with COVID-19 are at significantly increased risk for liver dysfunction afterward, according to a report posted […]
Créditos: Comité científico Covid
Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of SARS-CoV-2 infection.1 A previous study that described MIS-C cases in the first 3 waves of the COVID-19 pandemic found that the proportion of individuals with severe illness declined after the first wave.2 In Israel, the Omicron (B.1.1.529) variant started to spread […]
